Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $259,111 and 7, calls, for a total amount of $504,338.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $18.0 to $42.0 for Pfizer over the recent three months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of Pfizer stands at 4862.2, with a total volume reaching 36,883.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Pfizer, situated within the strike price corridor from $18.0 to $42.0, throughout the last 30 days.
Pfizer 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | PUT | TRADE | BULLISH | 02/07/25 | $0.19 | $0.17 | $0.17 | $24.00 | $124.0K | 22.0K | 7.3K |
| PFE | CALL | SWEEP | BULLISH | 01/24/25 | $1.49 | $1.48 | $1.49 | $25.00 | $121.1K | 331 | 3.5K |
| PFE | CALL | TRADE | BEARISH | 01/15/27 | $10.9 | $8.5 | $8.65 | $18.00 | $108.1K | 465 | 0 |
| PFE | CALL | SWEEP | BEARISH | 01/17/25 | $6.55 | $6.45 | $6.45 | $20.00 | $87.7K | 3.1K | 136 |
| PFE | CALL | TRADE | BEARISH | 06/20/25 | $6.55 | $6.5 | $6.5 | $20.00 | $65.0K | 1.7K | 100 |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance.
Pfizer's Current Market Status
- With a volume of 7,971,307, the price of PFE is down -0.67% at $26.54.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 22 days.
What The Experts Say On Pfizer
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $30.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Truist Securities has decided to maintain their Buy rating on Pfizer, which currently sits at a price target of $32. * Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Pfizer, targeting a price of $29.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pfizer with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
